Zhejiang Medicine Co Ltd (600216) - Net Assets

Latest as of March 2026: CN¥11.37 Billion CNY ≈ $1.66 Billion USD

Based on the latest financial reports, Zhejiang Medicine Co Ltd (600216) has net assets worth CN¥11.37 Billion CNY (≈ $1.66 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥14.18 Billion ≈ $2.07 Billion USD) and total liabilities (CN¥2.81 Billion ≈ $411.69 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 600216 tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥11.37 Billion
% of Total Assets	80.16%
Annual Growth Rate	13.7%
5-Year Change	20.77%
10-Year Change	58.6%
Growth Volatility	25.6

Zhejiang Medicine Co Ltd - Net Assets Trend (1997–2025)

This chart illustrates how Zhejiang Medicine Co Ltd's net assets have evolved over time, based on quarterly financial data. See Zhejiang Medicine Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Zhejiang Medicine Co Ltd (1997–2025)

The table below shows the annual net assets of Zhejiang Medicine Co Ltd from 1997 to 2025. For live valuation and market cap data, see market cap of Zhejiang Medicine Co Ltd.

Year	Net Assets	Change
2025-12-31	CN¥11.09 Billion ≈ $1.62 Billion	+2.03%
2024-12-31	CN¥10.87 Billion ≈ $1.59 Billion	+8.83%
2023-12-31	CN¥9.99 Billion ≈ $1.46 Billion	+2.85%
2022-12-31	CN¥9.71 Billion ≈ $1.42 Billion	+5.75%
2021-12-31	CN¥9.18 Billion ≈ $1.34 Billion	+14.35%
2020-12-31	CN¥8.03 Billion ≈ $1.18 Billion	-2.69%
2019-12-31	CN¥8.25 Billion ≈ $1.21 Billion	+2.08%
2018-12-31	CN¥8.08 Billion ≈ $1.18 Billion	+3.92%
2017-12-31	CN¥7.78 Billion ≈ $1.14 Billion	+11.26%
2016-12-31	CN¥6.99 Billion ≈ $1.02 Billion	+5.69%
2015-12-31	CN¥6.62 Billion ≈ $968.00 Million	+0.81%
2014-12-31	CN¥6.56 Billion ≈ $960.18 Million	+1.25%
2013-12-31	CN¥6.48 Billion ≈ $948.29 Million	+4.57%
2012-12-31	CN¥6.20 Billion ≈ $906.81 Million	+40.83%
2011-12-31	CN¥4.40 Billion ≈ $643.92 Million	+13.90%
2010-12-31	CN¥3.86 Billion ≈ $565.33 Million	+35.02%
2009-12-31	CN¥2.86 Billion ≈ $418.70 Million	+57.89%
2008-12-31	CN¥1.81 Billion ≈ $265.19 Million	+107.42%
2007-12-31	CN¥873.73 Million ≈ $127.85 Million	+12.40%
2006-12-31	CN¥777.31 Million ≈ $113.74 Million	+6.16%
2005-12-31	CN¥732.23 Million ≈ $107.15 Million	+13.40%
2004-12-31	CN¥645.68 Million ≈ $94.48 Million	+2.74%
2003-12-31	CN¥628.48 Million ≈ $91.97 Million	-0.20%
2002-12-31	CN¥629.71 Million ≈ $92.15 Million	+3.49%
2001-12-31	CN¥608.50 Million ≈ $89.04 Million	-4.18%
2000-12-31	CN¥635.03 Million ≈ $92.92 Million	+1.59%
1999-12-31	CN¥625.07 Million ≈ $91.47 Million	+79.30%
1998-12-31	CN¥348.61 Million ≈ $51.01 Million	+14.61%
1997-12-31	CN¥304.17 Million ≈ $44.51 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Zhejiang Medicine Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 22819.7% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥6.36 Billion	58.15%
Other Components	CN¥4.58 Billion	41.85%
Total Equity	CN¥10.94 Billion	100.00%

Zhejiang Medicine Co Ltd Competitors by Market Cap

The table below lists competitors of Zhejiang Medicine Co Ltd ranked by their market capitalization.

Company	Market Cap
MicroPort Scientific Corporation F:MSK	$1.62 Billion
HuBei SanFeng Intelligent Conveying Equipment Co Ltd SHE:300276	$1.62 Billion
Shenzhen Zhenye Group Co Ltd SHE:000006	$1.62 Billion
Alembic Pharmaceuticals Limited NSE:APLLTD	$1.62 Billion
Petrovietnam Power Corp VN:POW	$1.62 Billion
Fujian Snowman Co Ltd SHE:002639	$1.62 Billion
Siltronic AG XETRA:WAF	$1.62 Billion
Shenzhen Rayitek Hi-Tech Film Co. Ltd. A SHG:688323	$1.62 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zhejiang Medicine Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 10,648,142,085 to 10,943,373,741, a change of 295,231,656 (2.8%).
Net income of 873,380,229 contributed positively to equity growth.
Dividend payments of 376,692,920 reduced retained earnings.
Other comprehensive income decreased equity by 2,696,089,239.
Other factors increased equity by 2,494,633,586.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥873.38 Million	+7.98%
Dividends Paid	CN¥376.69 Million	-3.44%
Other Comprehensive Income	CN¥-2.70 Billion	-24.64%
Other Changes	CN¥2.49 Billion	+22.8%
Total Change	CN¥-	2.77%

Book Value vs Market Value Analysis

This analysis compares Zhejiang Medicine Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.01x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 30.57x to 1.01x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1997-12-31	CN¥0.38	CN¥11.52	x
1998-12-31	CN¥0.43	CN¥11.52	x
1999-12-31	CN¥0.77	CN¥11.52	x
2000-12-31	CN¥0.79	CN¥11.52	x
2001-12-31	CN¥0.75	CN¥11.52	x
2002-12-31	CN¥0.77	CN¥11.52	x
2003-12-31	CN¥0.78	CN¥11.52	x
2004-12-31	CN¥0.80	CN¥11.52	x
2005-12-31	CN¥0.90	CN¥11.52	x
2006-12-31	CN¥0.95	CN¥11.52	x
2007-12-31	CN¥1.11	CN¥11.52	x
2008-12-31	CN¥2.22	CN¥11.52	x
2009-12-31	CN¥3.52	CN¥11.52	x
2010-12-31	CN¥4.75	CN¥11.52	x
2011-12-31	CN¥5.42	CN¥11.52	x
2012-12-31	CN¥7.29	CN¥11.52	x
2013-12-31	CN¥6.86	CN¥11.52	x
2014-12-31	CN¥6.93	CN¥11.52	x
2015-12-31	CN¥6.93	CN¥11.52	x
2016-12-31	CN¥7.44	CN¥11.52	x
2017-12-31	CN¥7.77	CN¥11.52	x
2018-12-31	CN¥7.97	CN¥11.52	x
2019-12-31	CN¥8.20	CN¥11.52	x
2020-12-31	CN¥8.01	CN¥11.52	x
2021-12-31	CN¥9.16	CN¥11.52	x
2022-12-31	CN¥9.66	CN¥11.52	x
2023-12-31	CN¥10.09	CN¥11.52	x
2024-12-31	CN¥11.10	CN¥11.52	x
2025-12-31	CN¥11.38	CN¥11.52	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zhejiang Medicine Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 7.98%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 9.83%
• Asset Turnover: 0.63x
• Equity Multiplier: 1.29x
Recent ROE (7.98%) is below the historical average (10.62%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1997	12.22%	4.05%	0.97x	3.12x	CN¥6.73 Million
1998	10.45%	3.27%	0.97x	3.30x	CN¥1.53 Million
1999	5.36%	2.80%	0.69x	2.78x	CN¥-28.75 Million
2000	1.29%	0.76%	0.75x	2.27x	CN¥-55.19 Million
2001	2.73%	1.89%	0.55x	2.61x	CN¥-43.61 Million
2002	3.03%	1.68%	0.68x	2.64x	CN¥-43.17 Million
2003	0.92%	0.51%	0.68x	2.67x	CN¥-56.69 Million
2004	1.99%	0.92%	0.75x	2.87x	CN¥-51.29 Million
2005	11.27%	4.33%	0.85x	3.05x	CN¥9.18 Million
2006	7.59%	2.66%	0.87x	3.28x	CN¥-18.60 Million
2007	6.51%	2.56%	0.78x	3.27x	CN¥-30.30 Million
2008	54.05%	25.86%	1.15x	1.81x	CN¥792.68 Million
2009	42.60%	29.01%	1.08x	1.36x	CN¥928.84 Million
2010	29.68%	25.11%	0.98x	1.20x	CN¥758.99 Million
2011	23.06%	20.98%	0.93x	1.18x	CN¥573.39 Million
2012	13.72%	16.12%	0.75x	1.14x	CN¥229.90 Million
2013	7.00%	9.16%	0.65x	1.17x	CN¥-193.72 Million
2014	2.60%	3.51%	0.61x	1.20x	CN¥-484.09 Million
2015	2.45%	3.60%	0.55x	1.25x	CN¥-497.73 Million
2016	6.45%	8.53%	0.60x	1.26x	CN¥-247.72 Million
2017	3.47%	4.45%	0.58x	1.34x	CN¥-475.78 Million
2018	4.77%	5.32%	0.68x	1.31x	CN¥-400.13 Million
2019	4.36%	4.87%	0.68x	1.32x	CN¥-443.31 Million
2020	9.35%	9.79%	0.70x	1.37x	CN¥-50.06 Million
2021	11.91%	11.45%	0.73x	1.43x	CN¥167.41 Million
2022	5.83%	6.65%	0.65x	1.34x	CN¥-386.42 Million
2023	4.46%	5.51%	0.61x	1.33x	CN¥-533.43 Million
2024	10.90%	12.38%	0.68x	1.30x	CN¥95.70 Million
2025	7.98%	9.83%	0.63x	1.29x	CN¥-220.96 Million

Industry Comparison

This section compares Zhejiang Medicine Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $4,041,443,343
Average return on equity (ROE) among peers: 10.73%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Zhejiang Medicine Co Ltd (600216)	CN¥11.37 Billion	12.22%	0.25x	$1.62 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$971.04 Million	5.41%	3.98x	$565.97 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$1.33 Billion	6.10%	1.68x	$359.03 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$8.39 Billion	22.09%	0.19x	$4.30 Billion
Livzon Pharmaceutical Group Inc (000513)	$3.01 Billion	11.93%	0.53x	$2.52 Billion
Wedge Industrial Co Ltd (000534)	$1.15 Billion	11.42%	1.59x	$2.41 Billion
Yunnan Baiyao Group Co Ltd (000538)	$1.42 Billion	23.64%	1.01x	$12.64 Billion
Hainan Haiyao Co Ltd (000566)	$445.29 Million	14.73%	0.90x	$715.72 Million
Tus Pharmaceutical Group Co Ltd (000590)	$347.80 Million	3.58%	0.72x	$319.94 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$905.53 Million	2.15%	1.95x	$916.75 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$22.44 Billion	6.25%	0.15x	$3.00 Billion

About Zhejiang Medicine Co Ltd

SHG:600216 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.62 Billion

CN¥11.08 Billion CNY

Market Cap Rank

#7065 Global

#1607 in China

Share Price

CN¥11.52

Change (1 day)

-2.12%

52-Week Range

CN¥11.52 - CN¥18.38

All Time High

CN¥20.16